JP2025106480A5 - - Google Patents

Info

Publication number
JP2025106480A5
JP2025106480A5 JP2025064597A JP2025064597A JP2025106480A5 JP 2025106480 A5 JP2025106480 A5 JP 2025106480A5 JP 2025064597 A JP2025064597 A JP 2025064597A JP 2025064597 A JP2025064597 A JP 2025064597A JP 2025106480 A5 JP2025106480 A5 JP 2025106480A5
Authority
JP
Japan
Prior art keywords
micelle
units
moiety
positively charged
portion comprises
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025064597A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025106480A (ja
Filing date
Publication date
Priority claimed from PCT/IB2020/056093 external-priority patent/WO2020261227A1/en
Application filed filed Critical
Publication of JP2025106480A publication Critical patent/JP2025106480A/ja
Publication of JP2025106480A5 publication Critical patent/JP2025106480A5/ja
Pending legal-status Critical Current

Links

JP2025064597A 2019-06-26 2025-04-09 ミセルナノ粒子及びその使用 Pending JP2025106480A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201962867097P 2019-06-26 2019-06-26
US62/867,097 2019-06-26
US202063043693P 2020-06-24 2020-06-24
US63/043,693 2020-06-24
PCT/IB2020/056093 WO2020261227A1 (en) 2019-06-26 2020-06-26 Micellar nanoparticles and uses thereof
JP2021577297A JP7665540B2 (ja) 2019-06-26 2020-06-26 ミセルナノ粒子及びその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021577297A Division JP7665540B2 (ja) 2019-06-26 2020-06-26 ミセルナノ粒子及びその使用

Publications (2)

Publication Number Publication Date
JP2025106480A JP2025106480A (ja) 2025-07-15
JP2025106480A5 true JP2025106480A5 (cg-RX-API-DMAC7.html) 2025-07-25

Family

ID=74060198

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021577297A Active JP7665540B2 (ja) 2019-06-26 2020-06-26 ミセルナノ粒子及びその使用
JP2025064597A Pending JP2025106480A (ja) 2019-06-26 2025-04-09 ミセルナノ粒子及びその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021577297A Active JP7665540B2 (ja) 2019-06-26 2020-06-26 ミセルナノ粒子及びその使用

Country Status (14)

Country Link
US (3) US20220257790A1 (cg-RX-API-DMAC7.html)
EP (2) EP4603589A3 (cg-RX-API-DMAC7.html)
JP (2) JP7665540B2 (cg-RX-API-DMAC7.html)
KR (2) KR20240039234A (cg-RX-API-DMAC7.html)
CN (1) CN114514038B (cg-RX-API-DMAC7.html)
AU (1) AU2020303447A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021026365A2 (cg-RX-API-DMAC7.html)
CA (1) CA3144333A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022000316A2 (cg-RX-API-DMAC7.html)
DK (1) DK3990028T3 (cg-RX-API-DMAC7.html)
IL (1) IL289258A (cg-RX-API-DMAC7.html)
MX (1) MX2022000045A (cg-RX-API-DMAC7.html)
PE (1) PE20220902A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020261227A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10844380B1 (en) 2019-06-17 2020-11-24 Biorchestra Co., Ltd. Uses for prevention or treatment of brain diseases using microrna
CN114080412B (zh) 2019-06-28 2023-08-25 国立大学法人东京大学 蛋白质内包高分子胶束
CN115461085A (zh) * 2020-02-07 2022-12-09 生物欧赛加有限责任公司 miRNA-485抑制剂用于治疗tau蛋白病的用途
US11761874B2 (en) * 2020-05-15 2023-09-19 Saudi Arabian Oil Company CMC-based method for surfactant concentration determination
CN116322648A (zh) * 2020-10-09 2023-06-23 国立大学法人 东京大学 包封烟酰胺的胶束、以及含有包封烟酰胺的胶束的妊娠高血压综合征治疗用组合物
WO2022144811A1 (en) * 2020-12-30 2022-07-07 Biorchestra Co., Ltd. Micellar nanoparticles and uses thereof
CN116963722A (zh) * 2020-12-30 2023-10-27 生物欧赛加有限责任公司 胶束纳米粒子及其用途
US20250313835A1 (en) * 2022-07-07 2025-10-09 Biorchestra Co., Ltd. Micellar nanoparticles and uses thereof
CN115721608A (zh) * 2022-11-29 2023-03-03 陕西科技大学 一种靶向温度敏感性聚合物胶束、制备方法及应用
WO2024228119A1 (en) * 2023-05-01 2024-11-07 Biorchestra Co., Ltd. Mirna-485 inhibitors
WO2024228118A1 (en) * 2023-05-01 2024-11-07 Biorchestra Co., Ltd. Mirna-485 inhibitors
WO2025149946A1 (en) * 2024-01-10 2025-07-17 Biorchestra Co., Ltd. Micellar nanoparticles and uses thereof

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5219564A (en) * 1990-07-06 1993-06-15 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
CN100523215C (zh) 2000-12-01 2009-08-05 马普科技促进协会 介导rna干涉的小rna分子
JP2005534718A (ja) * 2002-06-26 2005-11-17 メディゲーネ オンコロギー ゲゼルシャフト ミット ベシュレンクテル ハフツング カチオンキャリヤー系において診断化合物および治療化合物を安定化させる新規方法
WO2005013901A2 (en) 2003-07-31 2005-02-17 Isis Pharmaceuticals, Inc. Oligomeric compounds and compositions for use in modulation of small non-coding rnas
US20050142581A1 (en) 2003-09-04 2005-06-30 Griffey Richard H. Microrna as ligands and target molecules
CA2556752C (en) 2004-02-23 2016-02-02 Genentech, Inc. Heterocyclic self-immolative linkers and conjugates
AU2005328382C1 (en) 2004-07-21 2013-01-24 Alnylam Pharmaceuticals, Inc. Oligonucleotides comprising a modified or non-natural nucleobase
US20080213891A1 (en) 2004-07-21 2008-09-04 Alnylam Pharmaceuticals, Inc. RNAi Agents Comprising Universal Nucleobases
EP1913011B1 (en) 2004-08-04 2016-11-02 Alnylam Pharmaceuticals Inc. Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase
US20070213292A1 (en) 2005-08-10 2007-09-13 The Rockefeller University Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
AU2006279906B2 (en) 2005-08-10 2012-05-10 Alnylam Pharmaceuticals, Inc. Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
ATE494372T1 (de) 2005-08-29 2011-01-15 Regulus Therapeutics Inc Verfahren für mir-122a-modulation
WO2007027894A2 (en) 2005-08-29 2007-03-08 Isis Pharmaceuticals, Inc. Antisense compounds having enhanced anti-microrna activity
EP2388328A1 (en) 2006-01-27 2011-11-23 Isis Pharmaceuticals, Inc. Oligomeric compounds and compositions for the use in modulation of micrornas
EA201100811A1 (ru) 2006-04-03 2012-06-29 Сантарис Фарма А/С Фармацевтическая композиция
CA3042781C (en) 2006-04-03 2021-10-19 Roche Innovation Center Copenhagen A/S Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
EP2090665A2 (en) 2006-10-20 2009-08-19 Exiqon A/S Novel human microRNAs associated with cancer
US20090137504A1 (en) 2006-12-21 2009-05-28 Soren Morgenthaler Echwald Microrna target site blocking oligos and uses thereof
US8580756B2 (en) 2007-03-22 2013-11-12 Santaris Pharma A/S Short oligomer antagonist compounds for the modulation of target mRNA
DK2205737T3 (da) 2007-10-04 2013-05-21 Santaris Pharma As Mikromirer
US20090156459A1 (en) * 2007-11-16 2009-06-18 Pharmain Corporation Cationic-Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
US8541435B2 (en) * 2008-07-11 2013-09-24 Uday Saxena Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of Alzheimer's disease (AD)
JP5622254B2 (ja) * 2009-03-31 2014-11-12 国立大学法人東京大学 二本鎖リボ核酸ポリイオンコンプレックス
US9034837B2 (en) 2009-04-24 2015-05-19 Roche Innovation Center Copenhagen A/S Pharmaceutical compositions for treatment of HCV patients that are poor-responders to interferon
LT2459220T (lt) * 2009-07-31 2020-12-28 Ascendis Pharma A/S Biologiškai suyrantys vandenyje netirpūs hidrogeliai polietilenglikolio pagrindu
CA2773737C (en) * 2009-09-09 2021-11-16 Pharmain Corporation Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
US20120005765A1 (en) * 2010-07-01 2012-01-05 Saint Louis University Animal model for parkinson's disease
WO2012038851A1 (en) 2010-09-24 2012-03-29 Pfizer Inc. Isoxazoline oximes as antiparasitic agents
US20140371292A1 (en) * 2011-08-10 2014-12-18 Ludwig-Maximilians-Universitat Munchen Method for the controlled intracellular delivery of nucleic acids
CA2932123C (en) * 2013-12-05 2022-05-31 Nian WU Polymer-carbohydrate conjugates for drug delivery technology
CN106456662A (zh) * 2014-02-24 2017-02-22 奥利金制药公司 口服给药的戊聚糖多硫酸盐的组合物及其使用方法
WO2016086177A2 (en) * 2014-11-25 2016-06-02 Drexel University Compositions and methods for hiv quasi-species excision from hiv-1-infected patients
DK3378482T5 (da) * 2015-11-19 2024-09-30 Univ Nagoya City Public Univ Corp Formulering til administration af antitumorlægemiddel
WO2017212007A1 (en) * 2016-06-09 2017-12-14 Curevac Ag Cationic carriers for nucleic acid delivery
CN110392583B (zh) 2016-09-15 2023-01-03 加利福尼亚大学董事会 改进的杂化的末端树枝状聚合物
RU2016146594A (ru) * 2016-11-28 2018-05-28 Общество С Ограниченной Ответственностью "Биофарм-Меморейн" Средство для лечения деменции различной этиологии
RU2019121801A (ru) 2016-12-14 2021-01-15 Лигандал, Инк. Композиции и способы для доставки полезной нагрузки в виде нуклеиновой кислоты и/или белка
WO2018139759A1 (ko) * 2017-01-26 2018-08-02 주식회사 바이오오케스트라 마이크로 rna를 이용한 알츠하이머병 진단방법
US11123304B2 (en) 2017-02-03 2021-09-21 The Brigham And Women's Hospital, Inc. Nanoparticles having poly(ester amide) polymer cores as drug delivery vehicles
CN110156971A (zh) 2018-02-13 2019-08-23 上海时莱生物技术有限公司 一种两亲性嵌段共聚物及其制备方法和纳米胶束载药系统
WO2019204799A1 (en) 2018-04-20 2019-10-24 University Of Pittsburgh -Of The Commonwealth System Of Higher Education Cationic amphiphilic polymers for codelivery of hydrophobic agents and nucleic acids
CN111632153B (zh) 2020-06-23 2023-02-24 宁夏医科大学 一种化学基因药物共载的靶向纳米递药系统及其制备方法
WO2022144812A1 (en) 2020-12-30 2022-07-07 Biorchestra Co., Ltd. Micellar nanoparticles and uses thereof
WO2022144811A1 (en) 2020-12-30 2022-07-07 Biorchestra Co., Ltd. Micellar nanoparticles and uses thereof

Similar Documents

Publication Publication Date Title
US11020487B2 (en) Compositions for introducing nucelic acid into cells
AU2014300980B2 (en) Compositions for introducing RNA into cells
JP2025126919A5 (cg-RX-API-DMAC7.html)
JP2023123491A5 (cg-RX-API-DMAC7.html)
CN109072238B (zh) 使用靶向结缔组织生长因子的rna复合物治疗特发性肺纤维化
JP2022538868A5 (cg-RX-API-DMAC7.html)
US20210121580A1 (en) Functionalized DNA Dendrimers For Gene Delivery To Cells
US12478684B2 (en) Oligonucleotide-polymer miktoarm conjugates and methods of use
Do et al. Difatty acyl-conjugated linear and cyclic peptides for siRNA delivery
WO2024147020A1 (en) Polymersomes for delivery of nucleic acid cargoes
CN114317545B (zh) 一种核酸适体及其应用
CN114901823A (zh) 诱导外显子50的跳读的反义核酸
US9579394B2 (en) Polyanion nanocomplexes for therapeutic applications
KR20240040112A (ko) 방법
WO2022219409A2 (en) Compositions containing nucleic acid nanoparticles and processes related to alteration of their physicochemical characteristics
TW202241461A (zh) 微胞奈米粒子及其用途
JP2024503302A5 (cg-RX-API-DMAC7.html)
Sarkar et al. Recent developments in the delivery of peptide nucleic acids (PNAs)
US20200347385A1 (en) METHOD FOR mRNA STABILIZATION
KR20240072931A (ko) 히스티딘을 포함하는 지질 나노입자 및 그 제조방법
JP2025504474A5 (cg-RX-API-DMAC7.html)
Nomani et al. Poly (amido amine) dendrimer silences the expression of epidermal growth factor receptor and p53 gene in vitro
Wu et al. Unlocking the potential of RNA-based therapeutics in the lung: current status and future
JP2026068029A (ja) 一本鎖核酸及びその用途
Kim Rational design of polymeric siRNA delivery systems